San Francisco Giants v New York Yankees

A-Rod received therapeutic use exemptions for testosterone for several seasons before Biogenesis hit

41 Comments

There’s a book coming out soon about the Biogenesis scandal. It’s called “Blood Sport: Alex Rodriguez, Biogenesis and the Quest to End Baseball’s Steroid Era” by Tim Elfrink of the Miami New Times and Gus Garcia-Roberts of Newsday. Sports Illustrated is running a very tasty excerpt from it today.

The subject: Alex Rodriguez, not surprisingly. And while part of it is sexy — apparently, the first words out of A-Rod’s mouth to Tony Bosch were “What were you giving Manny Ramiez?” — there’s a more significant and more interesting part of it all too. Specifically: about the many therapeutic use exemptions A-Rod received to legally take testosterone before he hooked up with Biogenesis.

Therapeutic Use Exemptions — or TUEs as they’re often called — allow players to take otherwise banned drugs if they demonstrate a medical need to do so. These days we hear about them most often in connection with stimulants like Adderall, which are used to treat attention deficit disorder. Of course, a far greater percentage of players in Major League Baseball have therapeutic use exemptions for ADD medicine than the population at large has ADD, and for this reasons many look at the TUEs given for them with suspicion. As a means of players to obtain performance enhancing drugs without having to worry about being suspended.

In the book excerpt we learn that A-Rod received multiple TUEs during his time with the Yankees. But they weren’t for ADD medication. They were for testosterone, which is a really damn rare exemption to get. But A-Rod got it:

Before the 2007 season, Rodriguez asked for permission to use testosterone, which has been banned by baseball since 2003. The IPA in ’07 was Bryan W. Smith, a High Point, N.C., physician. (Baseball did not yet have the advisory medical panel.) On Feb. 16, 2007, two days before Rodriguez reported to spring training, Smith granted the exemption, allowing Rodriguez to use testosterone all season.

A-Rod won the MVP that year and, at the end of the year, famously opted out of his Yankees deal and signed his ten-year contract extension. Even after securing what he had to know was his last professional contract, A-Rod continued to apply for and receive TUEs. In 2008 he received a TUE for Clomid, which is similar to the drug that Manny Ramirez got busted for when he was with the Dodgers. A-Rod took it with Major League Baseball’s approval, however.

I’d be pretty interested to learn more about those TUEs A-Rod got. Why he got them when, apparently, a lot of people didn’t. Whether MLB believes it had been too permissive with them back then and whether A-Rod’s decision to quit relying on those and, instead, go an illegal route with Tony Bosch, angered them in some way. I’d also be curious to know if there is a psychological dependency at work with testosterone and other such drugs and whether Major League Baseball approving A-Rod’s use of the stuff contributed to whatever it was that drove A-Rod to continue to take PEDs, long after he ceased to have much if anything to prove on a baseball diamond.

The Royals and Cardinals make a minor trade

FILE - In this Oct. 6, 2006 file photo, a freshly painted St. Louis Cardinals logo adorns the grass behind home plate at Busch Stadium in St. Louis. The St. Louis Cardinals have been the toast of their Midwestern town for generations, a source of civic pride as one of baseball's most successful and cherished franchises. Suddenly, they're an embarrassment, under federal investigation for the previously unprecedented crime of hacking into the computer database of an opponent, the Houston Astros, whose general manager, Jeff Luhnow, is a former Cardinals executive. (AP Photo/Tom Gannam, File)
Leave a comment

The St. Louis Cardinals just announced that they have acquired minor league outfielder Jose Martinez from the Royals in exchange for cash considerations.

Martinez was the 2015 Pacific Coast League batting champ, hitting .384 in 98 games. This year he’s hitting .298/.356/.433 in 37 games. He doesn’t have a ton of power — he’s more of a doubles guy — and turns 28 this year so he’s not a prospect but he’s not chopped liver.

Meanwhile, Cash Considerations continues to be well-traveled. It must be hard for him to be dealt so many times a season. So much uncertainty and time away from his family. Feel for the guy.

What’s On Tap: Previewing Wednesday’s afternoon action

160514 arrieta
Leave a comment

We have a lot of day games today.

Steven Matz and Tanner Roark are both coming off of good starts against lesser teams and now face tougher tests. Tyler Duffey is coming off of a terrible start and faces the defending world champs. The Tigers are on a roll but Anibal Sanchez has still struggled a lot. He’ll try to get back on track against the weak-hitting Phillies lineup.

Jake Arrieta goes against a struggling Carlos Martinez in St. Louis. Arrieta has, obviously, been on a roll, with the only person coming particularly close to him being Clayton Kershaw. After Kershaw’s two-hit shutout the other day we’ll see if Arrieta can do the anything you can do I can do better trick. Though doing it against St. Louis is a taller order than Kershaw doing it against Cincy.

No matter what happens, God help these guys if they don’t talk to the media afterward.

New York Mets (Steven Matz) @ Washington Nationals (Tanner Roark), 1:05 PM EDT, Nationals Park

Kansas City Royals (Dillon Gee) @ Minnesota Twins (Tyler Duffey), 1:10 PM EDT, Target Field

Philadelphia Phillies (Aaron Nola) @ Detroit Tigers (Anibal Sanchez), 1:10 PM EDT, Comerica Park

Chicago Cubs (Jake Arrieta) @ St. Louis Cardinals (Carlos Martinez), 1:45 PM EDT, Busch Stadium

Los Angeles Angels (Hector Santiago) @ Texas Rangers (Colby Lewis), 2:05 PM EDT, Globe Life Park in Arlington

Cleveland Indians (Corey Kluber) @ Chicago White Sox (Jose Quintana), 2:10 PM EDT, U.S. Cellular Field

San Diego Padres (James Shields) @ San Francisco Giants (Jake Peavy), 3:45 PM EDT, AT&T Park

 

 

Matt Harvey to make his next start

NEW YORK, NY - MAY 19: Pitcher Matt Harvey #33 of the New York Mets walks off the mound after being relieved during the third inning of a game against the Washington Nationals at Citi Field on May 19, 2016 in the Flushing neighborhood of the Queens borough of New York City. (Photo by Rich Schultz/Getty Images)
4 Comments

After Matt Harvey‘s bad start last night — his third in a row in a heretofore lost season — many speculated that he could be skipped, sent down or shut down. If that happens it won’t happen yet, however. The Mets just announced that Harvey will make his next start against the White Sox on Monday.

Matt Harvey could not be reached for comment, but I’m sure if he did comment it would be interesting and insightful and would totally change the manner in which he was handled by the New York press corps.

Video: Mike Napoli face-plants into third base after a triple

Screen Shot 2016-05-25 at 10.19.56 AM
2 Comments

Indians DH/1B Mike Napoli has hit ten triples in his 11-year big league career, so sliding into third base after a long run is not something with which he has tons of experience. As such, the slide — and I use that term in the loosest sense possible — he executed — and I use that term as loosely as possible too — when he hit a triple last night against the White Sox was somewhat unconventional.

The best part, though, was that he didn’t even need to slide as the throw from the outfield was delayed due to the outfielder not getting a great handle on the ball and the relay throw which never came was dropped by the infielder. He could’ve gone in standing up.

Thank God he didn’t, though, because this was too good: